Regulating drug prices while increasing innovation

New England Journal of Medicine

13 November 2021 - To save money on drugs while encouraging high-value pharmaceutical innovation, we need to better reward value, increase NIH funding for early-stage research, and reduce expenses and risks for developers of drugs whose social value exceeds their financial value.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing , Innovation